Bayesian Capital Management’s Cinemark Holdings CNK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-10,722
Closed -$232K 729
2024
Q2
$232K Buy
+10,722
New +$195K 0.03% 570
2024
Q1
Sell
-11,458
Closed -$161K 822
2023
Q4
$161K Buy
+11,458
New +$178K 0.02% 627
2023
Q1
Sell
-47,794
Closed -$414K 831
2022
Q4
$414K Buy
+47,794
New +$539K 0.06% 403
2022
Q3
Sell
-15,710
Closed -$236K 741
2022
Q2
$236K Buy
+15,710
New +$249K 0.04% 566
2020
Q4
Sell
-73,550
Closed -$736K 481
2020
Q3
$736K Buy
+73,550
New +$917K 0.18% 149
2020
Q1
Sell
-14,300
Closed -$484K 798
2019
Q4
$484K Sell
14,300
-3,000
-17% -$106K 0.08% 313
2019
Q3
$668K Buy
+17,300
New +$661K 0.13% 224
2018
Q2
Sell
-16,812
Closed -$633K 614
2018
Q1
$633K Buy
+16,812
New +$638K 0.16% 213

Other funds holding CNK

Bayesian Capital Management's CNK Position: Q3 2024 in Review

Bayesian Capital Management sold out of Cinemark Holdings (CNK) in Q3 2024, closing a stake of 10,722 shares — an estimated $232K sold.

Bayesian Capital Management first reported a position in CNK in Q1 2018 and held it in 8 quarters. The position peaked at $736K in Q3 2020. 277 funds tracked by Wall St. Rank hold CNK as of Q3 2024.

  • Bayesian Capital Management reported no remaining Cinemark Holdings position as of Q3 2024 after selling out during the quarter.
  • Bayesian Capital Management sold 10,722 Cinemark Holdings shares in Q3 2024, an estimated $232K.
  • Bayesian Capital Management first reported a position in Cinemark Holdings in Q1 2018 and held it in 8 quarters.
  • Bayesian Capital Management's Cinemark Holdings position peaked at $736K in Q3 2020.
  • 277 funds tracked by Wall St. Rank held Cinemark Holdings as of Q3 2024.

Based on Bayesian Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.